217 related articles for article (PubMed ID: 7855784)
1. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
[TBL] [Abstract][Full Text] [Related]
2. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
Goldsmith JM; Deutsche J; Tang M; Green D
Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
[TBL] [Abstract][Full Text] [Related]
3. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Mannucci PM; Gringeri A; de Biasi R; Baudo F; Morfini M; Ciavarella N
Thromb Haemost; 1992 Mar; 67(3):310-3. PubMed ID: 1353642
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
[TBL] [Abstract][Full Text] [Related]
5. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
Sabin C; Pasi J; Phillips A; Elford J; Janossy G; Lee C
Thromb Haemost; 1994 Aug; 72(2):214-7. PubMed ID: 7831654
[TBL] [Abstract][Full Text] [Related]
6. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
Lorenzo JI; Molina R; Aznar JA
Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
[TBL] [Abstract][Full Text] [Related]
7. [The effect of the type of factor VIII concentrate on the CD4 lymphocyte count in hemophiliacs with human immunodeficiency virus infection: the results of a meta-analysis].
Montoro Ronsano JB; Oliveras Martín J; Tusell Puigbert JM
Med Clin (Barc); 1994 Nov; 103(18):690-4. PubMed ID: 7808075
[TBL] [Abstract][Full Text] [Related]
8. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
Mannucci PM
Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
[TBL] [Abstract][Full Text] [Related]
9. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
[TBL] [Abstract][Full Text] [Related]
10. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
Smid WM; van der Meer J; Smit JW; Halie MR
Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
[TBL] [Abstract][Full Text] [Related]
11. Decrease of CD4 cell number and function in HIV-seropositive hemophiliacs in a longitudinal study.
Knutsen AP; Bouhasin JD; Joist JH; Scrivner D; Mueller KR; Gioia K; Janney S
Ann Allergy; 1989 Sep; 63(3):189-94. PubMed ID: 2528308
[TBL] [Abstract][Full Text] [Related]
12. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
Seremetis SV
Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
[No Abstract] [Full Text] [Related]
13. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2-year period.
Freedman J; Mazaheri R; Read S; Garvey MB; Teitel J
Diagn Clin Immunol; 1987; 5(1):30-40. PubMed ID: 2439226
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
Eichinger S; Pabinger I; Kyrle PA; Köller U; Kier P; Schneider B; Lechner K
Haemostasis; 1992; 22(1):25-31. PubMed ID: 1521824
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
Ikegami N
AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
[TBL] [Abstract][Full Text] [Related]
17. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
[TBL] [Abstract][Full Text] [Related]
18. Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.
Mannucci PM; Brettler DB; Aledort LM; Lusher JM; Abildgaard CF; Schwartz RS; Hurst D
Blood; 1994 Apr; 83(7):1958-62. PubMed ID: 7908234
[TBL] [Abstract][Full Text] [Related]
19. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
20. Immunological status and HIV antibodies in patients with haemophilia--a longitudinal study.
Fuchs D; Hausen A; Reibnegger G; Werner ER; Vinazzer H; Dierich MP; Wachter H
Wien Klin Wochenschr; 1988 Aug; 100(15):505-9. PubMed ID: 3140497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]